CHICAGO–(BUSINESS WIRE)–SeniorWell Expands Service to Florida
Author: Business Wire
Ocuphire Pharma Announces Results from Two Phase 2 Clinical Studies of Nyxol® Eye Drops
FARMINGTON HILLS, Mich.–(BUSINESS WIRE)–Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company focused on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders, announced statistically sig…
Global Antiglaucoma Drugs Market Analysis 2015-2019 and Forecast 2020-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Antiglaucoma Drugs Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. Where is the largest and fastest growing market for the antiglaucoma drugs? How does the market relate to the overal…
Aerpio Reports Third Quarter 2019 Financial Results and Provides Business Update
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today reported financial results for the third…
Aldeyra Therapeutics Reports Third-Quarter 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today re…
Alcon to Announce Third Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Announce Third Quarter 2019 Results
Alcon to Announce Third Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Announce Third Quarter 2019 Results
Glaukos Corporation Announces Third Quarter 2019 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
Aerie Pharmaceuticals Reports Third Quarter 2019 Financial Results, Updates Full-Year 2019 Guidance and Provides Business Update
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Pharmacy Times Continuing Education™ Presents Live Virtual Symposium on Novel Therapies for Treating Neuromyelitis Optica Spectrum Disorder
CRANBURY, N.J.–(BUSINESS WIRE)– #NMOSD–Pharmacy Times Continuing Education™ Presents Live Virtual Symposium on Novel Therapies for Treating Neuromyelitis Optica Spectrum Disorder
Stanton Optical, a Leading Eye Health Provider, Opens Fifth Retail Store in Greenville Area
GREENVILLE, S.C.–(BUSINESS WIRE)– #EyeExam–Stanton Optical, a retail brand of Now Optics, which is a leading eye health provider offering accessible and affordable eye care, announced the opening of its fifth retail store in the Greenville market (G…
ProtoKinetix AAGP® Operational Update
MARIETTA, Ohio–(BUSINESS WIRE)– #AAGP–ProtoKinetix AAGP® Operational Update November 6, 2019
Global Ophthalmology PACS Market 2020-2024 | Evolving Opportunities With Agfa-Gevaert NV and Carestream Health Inc. | Technavio
LONDON–(BUSINESS WIRE)– #healthcare–Technavio has been monitoring the global ophthalmology PACS market and the market is poised to grow by USD 59.9 million during 2020-2024
Samsung Bioepis Enters into Commercialization Agreement for Next-Generation Biosimilar Candidates
INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. announced today that it has entered into a new commercialization agreement with Biogen (Nasdaq: BIIB) for two biosimilar candidates under development by Samsung Bioepis, SB11 (ranibizumab) and …
Vision Plan Customer Satisfaction Increases, J.D. Power Finds
COSTA MESA, Calif.–(BUSINESS WIRE)–Overall customer satisfaction among vision plan members has increased in 2019, driven by improved perceptions of value and coverage, J.D. Power finds.
STAAR Surgical to Host Investor and Analyst Day on November 8, 2019
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced today that the Company will host an Investor and Ana…
Second Sight to Discuss Third Quarter 2019 Financial Results on November 14, 2019 Conference Call
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, will releas…
Stanton Optical, a Leading Eye Health Provider, Opens Fourth Retail Store in New Orleans Area
NEW ORLEANS–(BUSINESS WIRE)– #EyeExam–Stanton Optical a retail brand of Now Optics, which is a leading eye health provider, announced its fourth store opening in the New Orleans market.
Zenni Launches First Collaboration with Renowned Designer Cynthia Rowley, Debuts Fashion-Forward Holiday Eyewear Collection
NOVATO, Calif.–(BUSINESS WIRE)– #Collection–Zenni today launched the Cynthia Rowley Holiday Capsule Collection – its first-ever collaboration with world-renowned designer Cynthia Rowley.
IVERIC bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–IVERIC bio reported that on Nov. 1, the Company granted Dr. Abraham Scaria a non-statutory stock option to purchase 300,000 shares of common stock.